Download PDF
Thromb Haemost 2004; 92(06): 1450-1452
DOI: 10.1055/s-0037-1614304
Letters to the Editor
Schattauer GmbH

Recombinant factor VIIa in a patient with Glanzmann’s thrombasthenia undergoing gynecological surgery: open issues in light of successful treatment

Antonio Coppola
2   Centro di Coordinamento Regionale per le Emocoagulo-patie, Department of Clinical and Experimental Medicine
,
Antonella Tufano
2   Centro di Coordinamento Regionale per le Emocoagulo-patie, Department of Clinical and Experimental Medicine
,
Ernesto Cimino
2   Centro di Coordinamento Regionale per le Emocoagulo-patie, Department of Clinical and Experimental Medicine
,
Annalisa Agangi
1   Department of Gynecological and Obstetric Emergencies, “Federico II” University, Naples, Italy
,
Giuseppe Maria Maruotti
1   Department of Gynecological and Obstetric Emergencies, “Federico II” University, Naples, Italy
,
Pasquale Martinelli
1   Department of Gynecological and Obstetric Emergencies, “Federico II” University, Naples, Italy
,
Giovanni Di Minno
2   Centro di Coordinamento Regionale per le Emocoagulo-patie, Department of Clinical and Experimental Medicine
› Author Affiliations
Further Information

Publication History

Received 08 June 2004

Accepted after revision October 2004

Publication Date:
14 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Tengborn L, Peturson B. A patient wth Glanzmann’s thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thromb Haemost 1996; 75: 981-2.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Poon M-C, d’Oiron R. Recombinant activated factor VII (NovoSeven®) treatment of platelet-related bleeding disorders. Blood Coagul Fibrinolysis 2000; 1 (Suppl. 01) 55-68.
    PubMedGoogle Scholar
  • 3 Poon M-C, d’Oiron R, Von Depka M. et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann’s thrombasthenia: results of an international survey. J Thromb Haemost 2004; 02: 1096-103.
    CrossrefPubMedGoogle Scholar
  • 4 D’Andrea G, Colaizzo D, Vecchione G. et al. on behalf of the GLAnzmann’s Thrombasthenia Italian Team (GLATIT). Glanzmann’s Thrombasthenia: identification of 19 new mutations in 30 patients. Thromb Haemost 2002; 87: 1034-42.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Monroe DM, Hoffman M, Allen GA. et al. The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. Semin Thromb Hemost 2000; 26: 373-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 d’Oiron R, Menart C, Trzeciak MC. et al. Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann’s thrombasthenia undergoing invasive procedures. Thromb Haemost 2000; 83: 644-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Abshire CT Dose optimization of recombinant factor VIIa for control of mild to moderate bleeds in inhibitor patients: improved efficacy with higher dosing. Semin Hematol 2004; 41 (Suppl. 01) 3-7.
    CrossrefPubMedGoogle Scholar
  • 8 Santagostino E, Morfini M, Rocino A. et al. Relationship between Factor VII activity and clinical efficacy of recombinant factor VIIa given by continous infusion to patients with factor VIII inhibitors. Thromb Haemost 2001; 86: 954-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Kawaguchi C, Takahashi Y, Hanesaka Y. et al. The in vitro analysis of the coagulation mechanism of activated factor VII using thrombe-lastogram. Thromb Haemost 2002; 88: 768-72.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Gabriel DA, Carr M, Roberts HR. Monitoring coagulation and the clinical effects of recombinant Factor VIIa. Semin Hematol 2004; 41 (Suppl. 01) 20-4.
    CrossrefPubMedGoogle Scholar
  • 11 Robinson KL, Savoia H, Street AM. Thrombotic complications in two patients receiving NovoSeven®. Haemophilia 2000; 06: 349.
    PubMedGoogle Scholar
  • 12 Wielenga JJ, Siebel Y, van Buuren HR. et al. Use of recombinant factor VIIa and HLA matched platelets to prevent bleeding during and after major surgery in a patient with Glanzmann’s thrombasthenia. Haemophilia 1998; 04: 299.
    PubMedGoogle Scholar